Almac appoints new financial director

Company: Almac Group

Promotes Kevin Stephens to the role

Kevin Stephens became finance director of the Almac Group at the beginning of the year, to lead the financial management teams for all global operations.

Stephens qualified as a chartered accountant with Ernst & Young and then worked for 14 years at Kemira NI as financial controller.

He joined Almac in 2001 and following a number of varied financial roles within the organisation, became Almac UK group financial controller in 2007. He was promoted to vice president, finance, Almac Group, in 2009, and in 2010 was appointed to the Almac executive team as executive vice president, finance.

You may also like

Manufacturing

Almac completes a multi-million-pound investment enhancing cold chain capabilities in Craigavon

Almac Clinical Services, part of the Almac Group, has completed a multi-million-pound investment to enhance cold chain capabilities at its global headquarters in Craigavon, Northern Ireland
Manufacturing

Almac Group hits record £1 billion revenue milestone

Strong financials support expansion in manufacturing and clinical capabilities
Analysis

Overcoming the analytical method development hurdles associated with paediatric solid dosage forms

Developing analytical methods for paediatric solid dose products presents unique challenges that differ significantly from those encountered with adult formulations, reports Chloe Watson, Analytical Technical Leader at Almac Pharma Services
Manufacturing

Formosa Pharmaceuticals licenses Almac Discovery's bispecific ADC, ALM-401

The novel, first-in-class engineered bispecific antibody-drug conjugate (ADC) will be progressed through the next phases of CMC and drug development by Formosa
Regulatory

Almac launches PNPLA3 kit to support liver disease research

New tool enables deeper genetic insight into MASLD and MASH progression
Design & Build

Almac Pharma Services opens doors on £65m new commercial manufacturing facility

Centre of excellence is a timely response to emerging pipeline needs in highly potent drug development
You need to be a subscriber to read this article.
Click here to find out more.
Regulatory

Unlocking drug longevity: the crucial role of stability studies

In the intricate world of drug development, stability studies play a pivotal role by ensuring that both active pharmaceutical ingredients (APIs) and drug products maintain their integrity and efficacy with time
Subscribe now